Wednesday, June 23, 2021

Tag: InVivo Therapeutics

InVivo Therapeutics

InVivo Therapeutics is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. By modulating the healing environment to facilitate cell survival and growth, we have the opportunity...

InVivo Therapeutics scaffold device may improve spinal cord injury — 4 key insights

An investigational scaffold device from InVivo Therapeutics increases the likelihood that a patient with acute thoracic complete spinal cord injury will have a neurologic status 'conversion' from complete paraplegia to incomplete injury, according to...

Using a Mini-Scaffold to Help Treat Spinal Cord Injury

Patients suffering from complete spinal cord injuries have little to no treatment options that provide meaningful improvement in patient outcomes. Cambridge, Mass.-based InVivo Therapeutics is trying to change that. Co-founded in 2005 by MIT professor...

Experimental scaffold hasn’t reversed her paralysis, but she’s embraced life ‘with wheels as legs’

Jesi Stracham used to captivate biotech investors and inadvertently move markets with social media posts documenting her dogged quest to get out of her wheelchair and back onto her feet. These days, the energetic 24-year-old North...

The Year in Review: SCI Research Breakthroughs in 2015

As we cross the threshold into 2016, we are one step closer to our goal of finding a cure for paralysis. Moving full speed ahead towards that goal, Conquer Paralysis Now compiled a brief retrospective....

A shattering crash, an online chronicle, and an unexpected twist

In the age of social media, patients who test experimental treatments wield surprising clout. The tweets and the selfies, the uploaded video clips, felt like a natural way for Jesi Stracham to record her halting progress as she fought to recover from a motorcycle accident that had left her paralyzed from the chest down. She had no idea, as she tapped away at her iPhone from her hospital bed, what her bubbly posts would unleash.

The Race To Treat Spinal Cord Injury: A Comparative Analysis

Summary Four biotech companies are pursuing the treatment of spinal cord injury with the use of stem cell transplantation. Each company demonstrated efficacy in pre-clinical studies. The race is in the early stages but InVivo Therapeutics is...

First 2 spinal cord injury patients progress after InVivo’s Neuro-Spinal Scaffold — 5 key...

The first two patients to receive InVivo's Neuro-Spinal Scaffold for spinal cord injury are showing improvement three-to-six months after surgery. The first spinal cord injury patient was treated in October 2014 at Barrow Neurological Institute...

InVivo’s Neuro-Spinal Scaffold used for 2nd spinal cord injury patient

InVivo Therapeutics enrolled the second patient in their Neuro-Spinal Scaffold to treat traumatic spinal cord injury. The patient is enrolled at Carolinas Medical Center, part of the Carolinas HealthCare System in the study to evaluate...

InVivo Therapeutics Initiates First Clinical Trial of Neuro-Spinal Scaffold

Scaffold Designed to Facilitate Neural Growth in Spinal Cord Injury CAMBRIDGE, Mass.--(BUSINESS WIRE)--April 28, 2014-- InVivo Therapeutics Holdings Corp. (NVIV) announced today that it has begun shipment of its innovative investigational device, a degradable polymer...